Astera Labs, Inc. Common Stock
NASDAQ:ALABSemiconductors
+$39.44 today
- Market cap
- $37.88B
- Beta
- 3.96
- P/E (TTM)
- 264.2
- EPS (TTM)
- $1.57
Volume 4.57M
Average 5.72M
ALAB Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Astera Labs, Inc. Common StockNASDAQ: ALAB
Total Equity · Q2 FY2026 · quarter ended Jun 2026
Total equity rises 51.9% from a year ago
Total equity stood at $1.73B at the end of Q2 FY2026, up 51.9% from a year earlier and up 15.5% from the prior quarter.
Context
- Total equity amounted to 89.3% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Total equity increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +51.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 1.36B USD
- Year-over-year change
- +41.3%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.36B | +41.3% |
| FY2024 | 2024-12-31 | 964.8M | +512.9% |
| FY2023 | 2023-12-31 | 157.43M | +284.6% |
| FY2022 | 2022-12-31 | (85.29M) | — |
Total Equity vs competitors
How ALAB compares with its peers on the latest reported figures
- ALAB's Jun 2026 total equity of $1.73B is the 6th highest of the 7 companies compared; the peer median is $15.96B.
- Its year-over-year change of +51.9% is the 2nd highest of 7, against a peer median of +15.0%.
- Total equity amounts to 89.3% of total assets for ALAB, versus a peer median of 62.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Aug 2026 | $33.55B | -1.6% | -2.5% | 69.3% | |
| Sep 2026 | $19.19B | +15.4% | +3.7% | 52.1% | |
| Aug 2026 | $18.53B | +38.1% | -2.9% | 67.3% | |
| Jun 2026 | $13.39B | +6.9% | +5.3% | 51.4% | |
| Aug 2026 | $2.73B | +249.2% | +81.1% | 90.6% | |
| Jun 2026 | $1.73B | +51.9% | — | 89.3% | |
| Sep 2026 | $533.01M | +14.7% | -12.6% | 58.2% | |
| Peer median (excluding ALAB) | $15.96B | +15.0% | +0.6% | 62.7% | |
Competitors are the stored peer set for ALAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Astera Labs, Inc. Common Stock
NASDAQ:ALAB
Intrinsic Alpha fair value
Locked
Current Price
$216.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.